Collectively, we found that exosomal miR-1290 from CAFs could promote tumor growth and metastasis via downregulating GSK3β/β-catenin signaling, suggesting that inhibiting CAFs-derived exosomal miR-1290 may provide a new modality for the treatment of growth and metastasis in PC. Here, GSK3B is linked to neoplasm.